Visit Number | Screening for eligibility | Randomization | Blood examination, urinary test, liver and renal function, ECG | Surgical indicators, surgical complications | Gynecological examination | Imaging test | SCCA/CA-125 | Cervical liquid-based cytology | HPV test | Adverse events | EORTC QLQ-C30 v3.0; EORTC QLQ-CX24, PRO147(V1.0) |
---|---|---|---|---|---|---|---|---|---|---|---|
V0 |  ×  |  |  |  |  |  |  |  |  |  |  |
V1 |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  |
V2 (3 mos) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V3 (6 mos) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V4 (9 mos) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V5 (1 yr) |  |  |  |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |
V6 (15 mos) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V7 (1.5 yr) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V8 (21 mos) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V9 (2 yr) |  |  |  |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |
V10 (2.5 yr) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V11 (3 yr) |  |  |  |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |
V12 (3.5 yr) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V13 (4 yr) |  |  |  |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |
V14 (4.5 yr) |  |  |  |  |  ×  |  ×  |  ×  |  |  |  ×  |  ×  |
V15 (5 yr) |  |  |  |  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |  ×  |